The interval between the first and second doses of the nine-valent cervical cancer vaccine should not exceed 90 days at the latest.
Nine-valent cervical cancer vaccine is applicable to women aged 16-26 years, and one dose is generally recommended to be administered in 0, 2 and June respectively. Usually, after cervical cancer vaccination, the body can be induced to produce corresponding cervical cancer antibodies, thus providing a preventive effect.
The vaccination time of the vaccine 0 refers to the date of the first vaccination of the nine-valent cervical cancer vaccine, 2 refers to the interval of 2 months after the first vaccination and then the second vaccination, and 6 refers to the interval of 6 months after the first vaccination and the third vaccination. Vaccination can be delayed in special cases, not more than 1 month, so the latest interval between the first and second shots should not exceed 90 days.
If vaccination is needed, it is recommended to do it on time under the guidance of a doctor and not to delay vaccination to avoid the risk of infection exposure.